[1] |
Ding Qin, Zhang Shengkang, Ren Fei, Chen Xiaohong, Hu Chunmei, Chen Wei, Fan Lin.
Nutritional status of drug-resistant pulmonary tuberculosis patients and the influencing factors: a multi-center, large-sample study
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 826-832.
|
[2] |
Che Beibei, Wang Xiaoping, Qiu Qing, Chen Cheng, Zheng Xubin, Zhao Qi, Xu Biao.
A longitudinal study on the characteristics of diagnosis and treatment service of multidrug-resistant/rifampicin resistant pulmonary tuberculosis from 2009 to 2020 in Nantong City, Jiangsu Province
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 864-871.
|
[3] |
Du Yu, Zhang Haipeng, Wang Peng.
Research status and application progress of mycobacteria phages
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 897-903.
|
[4] |
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong.
The mechanisms identification of the susceptibility discrepancy to isoniazid among clinical isolates of Mycobacterium kansasii
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 728-733.
|
[5] |
Wang Nenhan, Tian Lili, Chen Shuangshuang, Zhao Yanfeng, Fan Ruifang, Chen Hao, Ren Yixuan, Zhang Jie, Yi Junli, Yang Xinyu, Yu Lan, Ding Beichuan, Li Chuanyou, Dai Xiaowei.
Study on the detection of rifampicin resistance of Mycobacterium tuberculosis in sputum samples using fluorescence PCR probe melting curve technique
[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 583-588.
|
[6] |
Wang Boning, Li Tao, Chen Wei.
Progress on economic burden of patients with drug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 607-612.
|
[7] |
Song Ruixue, Wei Rongrong, Dong Jing, Jia Hongyan, Du Boping, Sun Qi, Xing Aiying, Li Zihui, Zhu Chuanzhi, Zhang Zongde, Pan Liping.
The performance of interferon gamma-induced protein 10 mRNA detection technology in auxiliary diagnosis of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 471-476.
|
[8] |
Yan Xiaojing, Wang Qingfeng, Yang Yang, Chu Naihui, Nie Wenjuan.
Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in smear-negative pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 487-492.
|
[9] |
Fu Liang, Ren Tantan, Zhang Peize, Lu Shuihua.
Interpretation of WHO consolidated guidelines on tuberculosis, Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 336-348.
|
[10] |
Zhu Yumei, Xia Zihan, Li Jinli, He Huishan, Wang Feng.
Application value of multicolor melting curve analysis in detection of pre-extensive drug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 406-411.
|
[11] |
Zou Yuanwu, Li Jing, Wang Biao, Wang Zhuo, Qu Shaoyi, Yuan Zhimin, Wu Qianhong.
The diagnostic value of simultaneous amplification and testing for Mycobacterium tuberculosis technique on alveolar lavage fluid for diagnosing pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 434-436.
|
[12] |
Liu Yueyuan, Su Wei, Zheng Jiangang, Wang Meng, Zeng Zhong, Huang Qin, Xie Tian, Li Renzhong.
Study on the role of the prefectural tuberculosis designated hospital to improve the case finding of pulmonary tuberculosis in economic undeveloped areas of Jiangxi Province
[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 279-284.
|
[13] |
Yao Liming, Yao Xiaowei, Dong Zhaoliang, Liu Fengsheng, Wang Lianbo, Jia Chenguang.
Diagnostic value of metagenomic next-generation sequencing in hip or knee tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 292-296.
|
[14] |
Xu Jing, Jiang Shuangshuang, Zheng Hailun, Luo Ping.
Analysis of drug resistance characteristics and treatment outcomes of 290 patients with high risk of drug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 323-327.
|
[15] |
Liu Rongmei, Lyu Zizheng, Ma Liping, Li Qiang, Song Yanhua, Chen Hongmei, Kong Zhongshun, Gao Mengqiu.
Diagnostic application of GeneXpert MTB/RIF in stool specimens for intestinal tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 139-143.
|